Aluminum-containing adjuvants are widely used in preventive vaccines against infectious
diseases and in preparations for allergy immunotherapy. The mechanism by which they …

Vaccine-associated adverse events (VAAEs), including feline injection-site sarcomas
(FISSs), occur only rarely but can be severe. Understanding potential VAAEs is an important …

EXECUTIVE SUMMARY The WSAVA Vaccination Guidelines Group (VGG) was convened
in order to develop guidelines for the vaccination of dogs and cats that have global …

The guidelines are a consensus report on current recommendations for vaccination of cats
of any origin, authored by a Task Force of experts. The guidelines are published …

Rationale: This Report was developed by the Feline Vaccination Advisory Panel of the
American Association of Feline Practitioners (AAFP) to provide practical recommendations …

Overview: In cats, the most serious of adverse effects following vaccination is the occurrence
of invasive sarcomas (mostly fibrosarcomas): so-called 'feline injection-site …

Overview: Toxoplasma gondii infection is common in cats, but the clinical disease is rare. Up
to 50% of cats, especially free-roaming ones, have antibodies indicating infection and the …

Practical relevance: Feline injection site-associated sarcomas (FISSs) have been the cause
of much controversy and concern since they were first reported in the early 1990s. While not …

Feline injection site sarcomas (FISS; also known as vaccine-associated sarcomas) have
been recognized for> 20 years. Although uncommon, these tumors are iatrogenic, and …

Background Feline injection site sarcomas (FISS) are aggressive neoplasms that have been
associated with vaccination. In North America the incidence estimates have varied from 1 …